Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1368-2021Class II

A610 Clinician Programmer Application for Deep Brain Stimulation Clinician Programming Guide Percept PC Model...

Medtronic Neuromodulation / initiated 2021-03-09 / Open, Classified / root cause: software

Medtronic Neuromodulation began a recall of A610 Clinician Programmer Application for Deep Brain Stimulation Clinician Programming Guide Percept PC Model B35200 Neurostimulator Application, version... on . FDA classified it as Class II and gives the reason as "There are two issues within this correction action: 1. Cycling Issue: When copying settings from a previously used Activa device to a new Percept PC Implantable Neurostimulator (INS) using the "replacement" function of...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as software.

Recall record

Recall number
Z-1368-2021
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Medtronic Neuromodulation
Product
A610 Clinician Programmer Application for Deep Brain Stimulation Clinician Programming Guide Percept PC Model B35200 Neurostimulator Application, version 2.0.4584, 2.0.4594, 2.0.4605, and 3.0.1057* * Version 3.0.1057 is approved for distribution in Europe only.
Product code
MHY Stimulator, Electrical, Implanted, For Parkinsonian Tremor
Reason for recall
There are two issues within this correction action: 1. Cycling Issue: When copying settings from a previously used Activa device to a new Percept PC Implantable Neurostimulator (INS) using the "replacement" function of the A610 clinician programmer application, the cycling feature is not copied properly. 2. Log Fill Issue: When the Percept PC INS System Event log is full, the clinician programmer A610 Software application version 2.0.4584, 2.0.4594, 2.0.4605, or 3.0.1057 crashes when it attempts a reading of the last records in the log.
Root cause tag
software
FDA root cause
Under Investigation by firm
Action
Beginning 9-Mar-2021, Medtronic representatives began verbally notifications in order to inform impacted physicians of the issues and provide the mitigations outlined in the letters. Beginning 16-Mar-2021, Medtronic notified its consignees via mail, email, fax, and/or personal visit by Medtronic personnel. The notice described the problems and provided a workaround to use until a software update is available.
Quantity in commerce
5332 downloads
Distribution
Worldwide distribution - US Nationwide distribution in Puerto Rico and the countries of Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Japan, Lithuania, Luxembourg, Malaysia, Malta, Netherlands, Norway, Poland, Portugal, Saudi Arabia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Thailand, Turkey, United Kingdom.
Product codes and lots
version 2.0.4584, 2.0.4594, 2.0.4605, and 3.0.1057* * Version 3.0.1057 is approved for distribution in Europe only.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1368-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1368-2021Class IIOngoingVoluntary: Firm initiated